OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Boston University

11 Projects | 4 Researchers | $5,037,272 Invested

2024

Boston University

Rhoda Au, PhD

2023 Annual Goodes Prize for Excellence in Alzheimer's Drug Discovery: Validation of a Globally Scalable AD Screening Tool: A/T/dN

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Status: Active

2021

Boston University

Rhoda Au, PhD

Diagnostics Accelerator Speech & Language Consortium: Harmonized Repository for the Exploration of Speech and Language Biomarkers for Neurodegenerative Disease

  • Funding Amount: $844,285
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Active

2019

Boston University

Rhoda Au, PhD

Alzheimer’s Disease Digital Biomarker Discovery: Framingham Cognitive Aging and Dementia Study

  • Funding Amount: $1,937,857
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Other
  • Status: Active

2016

Boston University

Carmela Abraham, PhD

Development of Klotho Enhancers as Novel Therapeutics for AD (Bridge Funding)

  • Funding Amount: $215,293
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2015

Boston University

Carmela Abraham, PhD

Development of Klotho Enhancers as Novel Therapeutics for AD (Follow-On Funding)

  • Funding Amount: $236,516
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2014

Boston University

Alpaslan Dedeoglu, MD, PhD

Fingolimod therapy in models of Alzheimer's disease

  • Funding Amount: $148,954
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuroinflammation
  • Status: Closed

2014

Boston University

Carmela Abraham, PhD

Development of Klotho Enhancers as Novel Therapeutics for AD

  • Funding Amount: $344,305
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2013

Boston University

Carmela Abraham, PhD

Development of Klotho Enhancers as Novel Therapeutics for AD

  • Funding Amount: $266,509
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2012

Boston University

Carmela Abraham, PhD

Development of Klotho Enhancers as Novel Therapeutics for AD This is a request for Renewal/Follow-on funding.

  • Funding Amount: $196,421
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2009

Boston University

Carmela Abraham, PhD

Development of Klotho enhancers as novel therapeutics for AD

  • Funding Amount: $175,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed
View More